SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: blankmind who wrote (10167)6/28/1998 11:46:00 AM
From: Mkilloran  Read Replies (1) of 23519
 
blankmind....BigScane also stated that ALL the Muse that was already produced at the new plant would be shipped in the 2nd qtr as soon as they received FDA approval.

The big question is how much was produced at risk that wil be shipped ....what will this do to the 2nd qtr earnings...

EPS est for 2nd qtr is neg .17 cents....

How fast can ASTRA and Janssen now bring on new countries with Vivus's expanded capacity ?????.

Old plant may also stay inplace at reduced capacity due to contract agreement between Paco and Vivus.

Now if VVUS has a big surprise ...an extra million or more units selling in the 2nd qtr at reduced cost??? That could change the ballgame...

Bring on some large new countries ...it's going to be a fun 3rd and 4th qtr....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext